Difference between revisions of "Team:Bordeaux/Description"
Line 80: | Line 80: | ||
<p class="reference" align="left"> <b>Literature Cited: </b> </p> | <p class="reference" align="left"> <b>Literature Cited: </b> </p> | ||
− | <p class="reference" align="left"> [1] M. McIntosh (2005) Curdlan and other bacterial (1→3)-β-D-glucans mini review. Appl Microbiol Biotechnol 68: 163–173 </p> | + | <p class="reference" align="left"> [1] M. McIntosh (2005) Curdlan and other bacterial (1→3)-β-D-glucans mini review. <I> Appl Microbiol Biotechnol 68: 163–173 </i> </p> |
− | <p class="reference" align="left"> [2] M. McIntosh (2012) Recent advances in curdlan biosynthesis, biotechnological production, and applications. Appl Microbiol Biotechnol 93:525–531</p> | + | <p class="reference" align="left"> [2] M. McIntosh (2012) Recent advances in curdlan biosynthesis, biotechnological production, and applications. <i> Appl Microbiol Biotechnol 93:525–531 </i></p> |
− | <p class="reference" align="left"> [3] Adrien Gauthier (2014)The Sulfated Laminarin Triggers a Stress Transcriptome before Priming the SA- and ROS-Dependent Defenses during Grapevine’s Induced Resistance against Plasmopara viticola. Plos one 93:525–531</p> | + | <p class="reference" align="left"> [3] Adrien Gauthier (2014)The Sulfated Laminarin Triggers a Stress Transcriptome before Priming the SA- and ROS-Dependent Defenses during Grapevine’s Induced Resistance against Plasmopara viticola. <i>Plos one 93:525–531</i></p> |
<br> <br> <br> | <br> <br> <br> | ||
Line 195: | Line 195: | ||
<p class="reference" align="left"> <b>Literature Cited: </b> </p> | <p class="reference" align="left"> <b>Literature Cited: </b> </p> | ||
− | <p class="reference" align="left"> [1] M. McIntosh (2005) Curdlan and other bacterial (1→3)-β-D-glucans mini review. Appl Microbiol Biotechnol 68: 163–173 </p> | + | <p class="reference" align="left"> [1] M. McIntosh (2005) Curdlan and other bacterial (1→3)-β-D-glucans mini review. <i>Appl Microbiol Biotechnol 68: 163–173</i> </p> |
− | <p class="reference" align="left"> [2] R. Zhang and K. J. Edgar (2014) Properties, Chemistry, and Applications of the Bioactive Polysaccharide Curdlan. American Chemical Society | + | <p class="reference" align="left"> [2] R. Zhang and K. J. Edgar (2014) Properties, Chemistry, and Applications of the Bioactive Polysaccharide Curdlan. <i>American Chemical Society</i> |
− | <p class="reference" align="left"> [3] Zhang HB, Nishinari K, Williams MAK, Foster TJ, Norton IT (2002) A molecular description of the gelation mechanism of curdlan. Int J Biol Macromol 30:7–16</p> | + | <p class="reference" align="left"> [3] Zhang HB, Nishinari K, Williams MAK, Foster TJ, Norton IT (2002) A molecular description of the gelation mechanism of curdlan. <i>Int J Biol Macromol 30:7–16</i></p> |
− | <p class="reference" align="left"> [4] Nishinari K, Zhang H (2000) Curdlan. In: Phillips GO, Williams PA (eds) Handbook of hydrocolloids. CRC, Boca Raton, pp 269–286</p> | + | <p class="reference" align="left"> [4] Nishinari K, Zhang H (2000) Curdlan. In: Phillips GO, Williams PA (eds) Handbook of hydrocolloids. <i>CRC, Boca Raton, pp 269–286</i></p> |
− | <p class="reference" align="left"> [5] Spicer EJF, Goldenthal EI, Ikeda T (1999) A toxicological assessment of curdlan. Food Chem Toxicol 37:455–479</p> | + | <p class="reference" align="left"> [5] Spicer EJF, Goldenthal EI, Ikeda T (1999) A toxicological assessment of curdlan. <i>Food Chem Toxicol 37:455–479</i></p> |
− | <p class="reference" align="left"> [6] (2000) WHO food additives series. In: WHO (ed) 53rd Meeting of the joint FAO/WHO expert committee on food additives. JEFCA/WHO, Geneva</p> | + | <p class="reference" align="left"> [6] (2000) WHO food additives series. In: WHO (ed) 53rd Meeting of the joint FAO/WHO expert committee on food additives. <i>JEFCA/WHO, Geneva</i></p> |
− | <p class="reference" align="left"> [7] 21 CFR 172. Food additives permitted for direct addition to food for human consumption: curdlan. Federal Register 61:65941 </p> | + | <p class="reference" align="left"> [7] 21 CFR 172. Food additives permitted for direct addition to food for human consumption: curdlan.<i> Federal Register 61:65941 </i></p> |
− | <p class="reference" align="left"> [8] (1996) Bioproducts: bio-concrete. BioIndustry 13:56–57</p> | + | <p class="reference" align="left"> [8] (1996) Bioproducts: bio-concrete. <i>BioIndustry 13:56–57</i></p> |
− | <p class="reference" align="left"> [9] Harada T (1992) The story of research into curdlan and the bacteria producing it. Trends Glycosci Glycotechnol 4:309–317</p> | + | <p class="reference" align="left"> [9] Harada T (1992) The story of research into curdlan and the bacteria producing it. <i>Trends Glycosci Glycotechnol 4:309–317</i></p> |
− | <p class="reference" align="left"> [10] Kanke M, Tanabe E,(1995) Application of curdlan to controlled drug delivery. III. Drug release from sustained release suppositories in vitro. BiolPharm Bull 18:1154–1158</p> | + | <p class="reference" align="left"> [10] Kanke M, Tanabe E,(1995) Application of curdlan to controlled drug delivery. III. Drug release from sustained release suppositories in vitro.<i> BiolPharm Bull 18:1154–1158</i></p> |
− | <p class="reference" align="left"> [11] Janeway CA, Medzhitov R (2002) Innate immune recognition. Annu Rev Immunol 20:197–216</p> | + | <p class="reference" align="left"> [11] Janeway CA, Medzhitov R (2002) Innate immune recognition. <i>Annu Rev Immunol 20:197–216</i></p> |
<p class="reference" align="left"> [12] Toida T, Chaidedgumjorn A, Linhardt RJ (2003) Structure and bio- | <p class="reference" align="left"> [12] Toida T, Chaidedgumjorn A, Linhardt RJ (2003) Structure and bio- | ||
− | activity of sulphated polysaccharides. Trends Glycosci Glycotechnol 15:29–46 </p> | + | activity of sulphated polysaccharides. <i>Trends Glycosci Glycotechnol 15:29–46</i> </p> |
− | <p class="reference" align="left"> [13] Jagodzinski PP, Wiaderkiewicz R (1994) Mechanism of the inhibitory effect of curdlan sulphate on HIV-1 infection in vitro. Virology 202:735–745 </p> | + | <p class="reference" align="left"> [13] Jagodzinski PP, Wiaderkiewicz R (1994) Mechanism of the inhibitory effect of curdlan sulphate on HIV-1 infection in vitro. <i>Virology 202:735–745 </i></p> |
− | <p class="reference" align="left"> [14] Evans SG, Morrison D, Kaneko Y, Havlik I (1998) The effect of curdlan sulphate on development in vitro of Plasmodium falciparum. Trans R Soc Trop Med Hyg 92:87–89 </p> | + | <p class="reference" align="left"> [14] Evans SG, Morrison D, Kaneko Y, Havlik I (1998) The effect of curdlan sulphate on development in vitro of Plasmodium falciparum. <i>Trans R Soc Trop Med Hyg 92:87–89 </i></p> |
− | <p class="reference" align="left"> [15]Chanzy H, Vuong R (1985) Ultrastructure and morphology of crystalline polysaccharides. In Atkins EDT (ed) Polysaccharides: topics in structure and morphology. Macmillan, London, pp 41–71 </p> | + | <p class="reference" align="left"> [15]Chanzy H, Vuong R (1985) Ultrastructure and morphology of crystalline polysaccharides. In Atkins EDT (ed) Polysaccharides: topics in structure and morphology. <i>Macmillan, London, pp 41–71</i> </p> |
− | <p class="reference" align="left"> [16]Menard R, Alban S, (2004) β-1,3 Glucan Sulfate, but | + | <p class="reference" align="left"> [16]Menard R, Alban S, (2004) β-1,3 Glucan Sulfate, but not β-1,3 Glucan, Induces the Salicylic Acid Signaling Pathway in Tobacco and Arabidopsis </p> |
</div> | </div> | ||
</div> | </div> |
Revision as of 19:33, 16 September 2015